Filter News
Area of Research
- (-) Isotopes (12)
- (-) Neutron Science (12)
- (-) Supercomputing (30)
- Advanced Manufacturing (1)
- Biology and Environment (14)
- Clean Energy (59)
- Computer Science (2)
- Electricity and Smart Grid (1)
- Energy Sciences (1)
- Functional Materials for Energy (2)
- Fusion and Fission (3)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Materials (38)
- Materials for Computing (6)
- National Security (9)
- Nuclear Science and Technology (6)
- Sensors and Controls (1)
News Type
News Topics
- (-) Coronavirus (10)
- (-) Energy Storage (12)
- (-) Frontier (16)
- (-) Isotopes (11)
- (-) Security (4)
- (-) Space Exploration (4)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (2)
- Artificial Intelligence (17)
- Big Data (7)
- Bioenergy (8)
- Biology (8)
- Biomedical (17)
- Biotechnology (1)
- Buildings (2)
- Chemical Sciences (5)
- Climate Change (6)
- Composites (1)
- Computer Science (50)
- Critical Materials (3)
- Cybersecurity (7)
- Decarbonization (3)
- Environment (13)
- Exascale Computing (11)
- Fusion (2)
- Grid (4)
- High-Performance Computing (20)
- Irradiation (1)
- Machine Learning (7)
- Materials (21)
- Materials Science (20)
- Microscopy (6)
- Molten Salt (1)
- Nanotechnology (13)
- National Security (5)
- Neutron Science (66)
- Nuclear Energy (6)
- Partnerships (1)
- Physics (12)
- Polymers (2)
- Quantum Computing (9)
- Quantum Science (19)
- Simulation (5)
- Software (1)
- Summit (21)
- Sustainable Energy (8)
- Transportation (5)
Media Contacts
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Balendra Sutharshan, deputy associate laboratory director for operational systems at DOE’s Pacific Northwest National Laboratory, has joined ORNL as associate laboratory director for the Isotope Science and Engineering Directorate.
To better understand the spread of SARS-CoV-2, the virus that causes COVID-19, Oak Ridge National Laboratory researchers have harnessed the power of supercomputers to accurately model the spike protein that binds the novel coronavirus to a human cell receptor.
A better way of welding targets for Oak Ridge National Laboratory’s plutonium-238 production has sped up the process and improved consistency and efficiency. This advancement will ultimately benefit the lab’s goal to make enough Pu-238 – the isotope that powers NASA’s deep space missions – to yield 1.5 kilograms of plutonium oxide annually by 2026.
Brian Damiano, head of the Centrifuge Engineering and Fabrication Section, has been elected fellow of the American Society of Mechanical Engineers.
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.